المؤلفون: Makranz C; Department of Oncology and Neurology, Leslie and Michael Gaffin Center for Neuro-Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel., Khutsurauli S; Department of Oncology, Sharet Institute for Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel., Kalish Y; Department of Hematology, Sharet Institute for Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel., Eliahou R; Department of Radiology, Sharet Institute for Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel., Kadouri L; Department of Oncology, Sharet Institute for Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel., Gomori JM; Department of Radiology, Sharet Institute for Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel., Lossos A; Department of Oncology and Neurology, Leslie and Michael Gaffin Center for Neuro-Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.

المصدر: Molecular and clinical oncology [Mol Clin Oncol] 2018 Jan; Vol. 8 (1), pp. 178-182. Date of Electronic Publication: 2017 Nov 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Spandidos Publications UK Ltd Country of Publication: England NLM ID: 101613422 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2049-9450 (Print) Linking ISSN: 20499450 NLM ISO Abbreviation: Mol Clin Oncol Subsets: PubMed not MEDLINE